Co
Not verified

Contineum Therapeutics, Inc.

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsWEB AND SOCIAL NETWORK
15/05/2025
Eventi
WEB AND SOCIAL NETWORK
Biotechnology
Pharmaceuticals
Health
Medicine - various
Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
1.00
14/05/2025
stock market
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
1.00
28/04/2025
Labour market
Finance
stock market
Health
HIV, AIDS and autoimmune disorders
Sanità
Pharmaceuticals
Biotechnology
Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development
1.00
17/03/2025
Labour market
Scienza
Biotechnology
Pharmaceuticals
Health
HIV, AIDS and autoimmune disorders
Medicine - various
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors
1.00
12/03/2025
Eventi
WEB AND SOCIAL NETWORK
Health
Sanità
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
1.00
06/03/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
1.00
04/03/2025
Industria
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791
1.00
03/03/2025
Biotechnology
Pharmaceuticals
Health
Eventi
WEB AND SOCIAL NETWORK
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
1.00
16/12/2024
Industria
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
1.00

Contact details

Social Media

Followers
0
Compatibility
0